Note: Ingredients listed on restricted chemical lists
EC/CAS
231-595-7/7647-01-0
Name of the chemical
Hydrochloric acid
Concentration
**
EC/CAS
215-185-5/1310-73-2
Name of the chemical
sodium hydroxide
Concentration
**
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
* standards for the exact percentage
General Information
Version
MSDS/Onda-AUS/DP-003
Revision date
2020-04-03
Product name
Ondansetron Injection 4 mg/2 mL and 8 mg/4 mL
1.2.1 Relevant identified uses
Pharmaceutical product for the treatment of nausea and vomiting (antiemetic)
Manufacturer Name
Sponsor
Icons in SDS
Company Information
company name
Intas Pharmaceuticals Ltd
GHS Information
Signal word
Not Classified
Section 2
SECTION 2: Hazards identification
Classification of the Substance or Mixture GHS – Classification Not classified as hazardous
Signal word
Not Classified
Hazard statements
Non-hazardous in accordance with international standards for workplace safety.
2.3 Other hazards
An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8). Note This document has been prepared in accordance with standards for workplace safety, which requires the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warning included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
Label Elements: Signal Word
